Review



pparγ antagonist t0070907  (TargetMol)


Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    TargetMol pparγ antagonist t0070907
    Pparγ Antagonist T0070907, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pparγ antagonist t0070907/product/TargetMol
    Average 93 stars, based on 4 article reviews
    pparγ antagonist t0070907 - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    95
    MedChemExpress pparγ antagonist t0070907
    Pparγ Antagonist T0070907, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pparγ antagonist t0070907/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    pparγ antagonist t0070907 - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    93
    TargetMol pparγ antagonist t0070907
    Pparγ Antagonist T0070907, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pparγ antagonist t0070907/product/TargetMol
    Average 93 stars, based on 1 article reviews
    pparγ antagonist t0070907 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Cayman Chemical pparγ antagonist t0070907
    ZBTB9 is a positive regulator of PPARγ signaling in mature adipocytes. A , Co-IP using anti-RXRα antibody of exogenously expressed proteins as indicated in differentiated 3T3-L1 cells. B , PPRE luciferase reporter activity from 293T cells transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. Cells were treated with one μΜ PPARγ antagonist <t>T0070907</t> (PPARγi) or DMSO as a control (Two-way ANOVA, a Treatment∗overexpression p < 0.0001, b Treatment p < 0.0001, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). C , Pparg gene expression measured by qRT-PCR and ( D ) PPARγ protein level in 293T cells transfected with plasmids as indicated (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). Cell lysates were subjected to SDS-PAGE and western blotting for PPARγ. Vinculin represents a loading control. E , PPARγ protein levels from panel D were quantified by Image J (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). F , PPRE luciferase reporter activity from differentiated 3T3-L1 adipocytes transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. G , Zbtb9 was knocked down in differentiated 3T3-L1 adipocytes with 2 independent shRNAs targeting Zbtb9 (shRNA #1, shRNA #2) and compared to the control shRNA (shCtrl). Gene expression was measured by qRT-PCR. H , Pparg gene expression and ( I ) protein level (PPARγ2 and PPARγ1) in Zbtb9 -KD 3T3-L1 mature adipocytes and control cells. Vinculin represents a loading control. J , PPARγ2 and PPARγ1 protein levels from panel I were quantified by Image J. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant.
    Pparγ Antagonist T0070907, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pparγ antagonist t0070907/product/Cayman Chemical
    Average 90 stars, based on 1 article reviews
    pparγ antagonist t0070907 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Selleck Chemicals pparγ antagonist t0070907
    ZBTB9 is a positive regulator of PPARγ signaling in mature adipocytes. A , Co-IP using anti-RXRα antibody of exogenously expressed proteins as indicated in differentiated 3T3-L1 cells. B , PPRE luciferase reporter activity from 293T cells transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. Cells were treated with one μΜ PPARγ antagonist <t>T0070907</t> (PPARγi) or DMSO as a control (Two-way ANOVA, a Treatment∗overexpression p < 0.0001, b Treatment p < 0.0001, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). C , Pparg gene expression measured by qRT-PCR and ( D ) PPARγ protein level in 293T cells transfected with plasmids as indicated (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). Cell lysates were subjected to SDS-PAGE and western blotting for PPARγ. Vinculin represents a loading control. E , PPARγ protein levels from panel D were quantified by Image J (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). F , PPRE luciferase reporter activity from differentiated 3T3-L1 adipocytes transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. G , Zbtb9 was knocked down in differentiated 3T3-L1 adipocytes with 2 independent shRNAs targeting Zbtb9 (shRNA #1, shRNA #2) and compared to the control shRNA (shCtrl). Gene expression was measured by qRT-PCR. H , Pparg gene expression and ( I ) protein level (PPARγ2 and PPARγ1) in Zbtb9 -KD 3T3-L1 mature adipocytes and control cells. Vinculin represents a loading control. J , PPARγ2 and PPARγ1 protein levels from panel I were quantified by Image J. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant.
    Pparγ Antagonist T0070907, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pparγ antagonist t0070907/product/Selleck Chemicals
    Average 90 stars, based on 1 article reviews
    pparγ antagonist t0070907 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology pparγ antagonists t0070907
    ZBTB9 is a positive regulator of PPARγ signaling in mature adipocytes. A , Co-IP using anti-RXRα antibody of exogenously expressed proteins as indicated in differentiated 3T3-L1 cells. B , PPRE luciferase reporter activity from 293T cells transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. Cells were treated with one μΜ PPARγ antagonist <t>T0070907</t> (PPARγi) or DMSO as a control (Two-way ANOVA, a Treatment∗overexpression p < 0.0001, b Treatment p < 0.0001, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). C , Pparg gene expression measured by qRT-PCR and ( D ) PPARγ protein level in 293T cells transfected with plasmids as indicated (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). Cell lysates were subjected to SDS-PAGE and western blotting for PPARγ. Vinculin represents a loading control. E , PPARγ protein levels from panel D were quantified by Image J (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). F , PPRE luciferase reporter activity from differentiated 3T3-L1 adipocytes transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. G , Zbtb9 was knocked down in differentiated 3T3-L1 adipocytes with 2 independent shRNAs targeting Zbtb9 (shRNA #1, shRNA #2) and compared to the control shRNA (shCtrl). Gene expression was measured by qRT-PCR. H , Pparg gene expression and ( I ) protein level (PPARγ2 and PPARγ1) in Zbtb9 -KD 3T3-L1 mature adipocytes and control cells. Vinculin represents a loading control. J , PPARγ2 and PPARγ1 protein levels from panel I were quantified by Image J. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant.
    Pparγ Antagonists T0070907, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pparγ antagonists t0070907/product/Santa Cruz Biotechnology
    Average 92 stars, based on 1 article reviews
    pparγ antagonists t0070907 - by Bioz Stars, 2026-02
    92/100 stars
      Buy from Supplier

    90
    Cayman Chemical pparγ antagonists t0070907 (35 μm)
    ZBTB9 is a positive regulator of PPARγ signaling in mature adipocytes. A , Co-IP using anti-RXRα antibody of exogenously expressed proteins as indicated in differentiated 3T3-L1 cells. B , PPRE luciferase reporter activity from 293T cells transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. Cells were treated with one μΜ PPARγ antagonist <t>T0070907</t> (PPARγi) or DMSO as a control (Two-way ANOVA, a Treatment∗overexpression p < 0.0001, b Treatment p < 0.0001, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). C , Pparg gene expression measured by qRT-PCR and ( D ) PPARγ protein level in 293T cells transfected with plasmids as indicated (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). Cell lysates were subjected to SDS-PAGE and western blotting for PPARγ. Vinculin represents a loading control. E , PPARγ protein levels from panel D were quantified by Image J (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). F , PPRE luciferase reporter activity from differentiated 3T3-L1 adipocytes transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. G , Zbtb9 was knocked down in differentiated 3T3-L1 adipocytes with 2 independent shRNAs targeting Zbtb9 (shRNA #1, shRNA #2) and compared to the control shRNA (shCtrl). Gene expression was measured by qRT-PCR. H , Pparg gene expression and ( I ) protein level (PPARγ2 and PPARγ1) in Zbtb9 -KD 3T3-L1 mature adipocytes and control cells. Vinculin represents a loading control. J , PPARγ2 and PPARγ1 protein levels from panel I were quantified by Image J. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant.
    Pparγ Antagonists T0070907 (35 μm), supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pparγ antagonists t0070907 (35 μm)/product/Cayman Chemical
    Average 90 stars, based on 1 article reviews
    pparγ antagonists t0070907 (35 μm) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    ZBTB9 is a positive regulator of PPARγ signaling in mature adipocytes. A , Co-IP using anti-RXRα antibody of exogenously expressed proteins as indicated in differentiated 3T3-L1 cells. B , PPRE luciferase reporter activity from 293T cells transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. Cells were treated with one μΜ PPARγ antagonist T0070907 (PPARγi) or DMSO as a control (Two-way ANOVA, a Treatment∗overexpression p < 0.0001, b Treatment p < 0.0001, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). C , Pparg gene expression measured by qRT-PCR and ( D ) PPARγ protein level in 293T cells transfected with plasmids as indicated (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). Cell lysates were subjected to SDS-PAGE and western blotting for PPARγ. Vinculin represents a loading control. E , PPARγ protein levels from panel D were quantified by Image J (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). F , PPRE luciferase reporter activity from differentiated 3T3-L1 adipocytes transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. G , Zbtb9 was knocked down in differentiated 3T3-L1 adipocytes with 2 independent shRNAs targeting Zbtb9 (shRNA #1, shRNA #2) and compared to the control shRNA (shCtrl). Gene expression was measured by qRT-PCR. H , Pparg gene expression and ( I ) protein level (PPARγ2 and PPARγ1) in Zbtb9 -KD 3T3-L1 mature adipocytes and control cells. Vinculin represents a loading control. J , PPARγ2 and PPARγ1 protein levels from panel I were quantified by Image J. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant.

    Journal: The Journal of Biological Chemistry

    Article Title: Cell-state-dependent regulation of PPARγ signaling by the transcription factor ZBTB9 in adipocytes

    doi: 10.1016/j.jbc.2024.107985

    Figure Lengend Snippet: ZBTB9 is a positive regulator of PPARγ signaling in mature adipocytes. A , Co-IP using anti-RXRα antibody of exogenously expressed proteins as indicated in differentiated 3T3-L1 cells. B , PPRE luciferase reporter activity from 293T cells transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. Cells were treated with one μΜ PPARγ antagonist T0070907 (PPARγi) or DMSO as a control (Two-way ANOVA, a Treatment∗overexpression p < 0.0001, b Treatment p < 0.0001, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). C , Pparg gene expression measured by qRT-PCR and ( D ) PPARγ protein level in 293T cells transfected with plasmids as indicated (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). Cell lysates were subjected to SDS-PAGE and western blotting for PPARγ. Vinculin represents a loading control. E , PPARγ protein levels from panel D were quantified by Image J (Two-way ANOVA, a Treatment∗overexpression p not significant, b Treatment p not significant, c Overexpression p < 0.0001, followed by Sídak's multiple comparisons test). F , PPRE luciferase reporter activity from differentiated 3T3-L1 adipocytes transfected with an empty vector, Zbtb9 cDNA, Pparg cDNA as indicated. G , Zbtb9 was knocked down in differentiated 3T3-L1 adipocytes with 2 independent shRNAs targeting Zbtb9 (shRNA #1, shRNA #2) and compared to the control shRNA (shCtrl). Gene expression was measured by qRT-PCR. H , Pparg gene expression and ( I ) protein level (PPARγ2 and PPARγ1) in Zbtb9 -KD 3T3-L1 mature adipocytes and control cells. Vinculin represents a loading control. J , PPARγ2 and PPARγ1 protein levels from panel I were quantified by Image J. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001, ns: not significant.

    Article Snippet: PPARγ antagonist T0070907 was added to the cell culture 4h after transfection (1 μΜ, #10026, Cayman Chemical, Ann Arbor, MI).

    Techniques: Co-Immunoprecipitation Assay, Luciferase, Activity Assay, Transfection, Plasmid Preparation, Control, Over Expression, Gene Expression, Quantitative RT-PCR, SDS Page, Western Blot, shRNA